Futura Medical (LON:FUM) Shares Down 15.8% – Here’s What Happened

Shares of Futura Medical plc (LON:FUM) dropped 15.8% during mid-day trading on Thursday . The company traded as low as GBX 0.20 and last traded at GBX 0.28. 18,645,404 shares were traded during trading, an increase of 102% from the average daily volume of 9,214,374 shares. The stock had previously closed at GBX 0.33.

Futura Medical Stock Performance

The stock has a market capitalization of £1.62 million, a price-to-earnings ratio of -0.10 and a beta of 0.02. The company’s 50 day moving average is GBX 0.42 and its 200 day moving average is GBX 0.78.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. On average, equities research analysts anticipate that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.